+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Carotid Artery Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Carotid Artery Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Venous Insufficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Venous Insufficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Congenital Heart Defect - Pipeline Insight, 2024 - Product Thumbnail Image

Congenital Heart Defect - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
ANCA Vasculitis - Pipeline Insight, 2024 - Product Thumbnail Image

ANCA Vasculitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Postpartum Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Postpartum Hemorrhage - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Obstructive Hypertrophic Cardiomyopathy (HCM) - Pipeline Insight, 2024 - Product Thumbnail Image

Obstructive Hypertrophic Cardiomyopathy (HCM) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Granulomatosis with polyangiitis - Pipeline Insight, 2024 - Product Thumbnail Image

Granulomatosis with polyangiitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Myocarditis - Pipeline Insight, 2024 - Product Thumbnail Image

Myocarditis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) - Pipeline Insight, 2024 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Familial Primary Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Familial Primary Pulmonary Hypertension - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Heparin-Induced thrombocytopenia (HIT) - Pipeline Insight, 2024 - Product Thumbnail Image

Heparin-Induced thrombocytopenia (HIT) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Intracranial Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Intracranial Hemorrhage - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Microvascular Angina - Pipeline Insight, 2024 - Product Thumbnail Image

Microvascular Angina - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hypercholesterolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypercholesterolemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Arteriovenous Malformations - Pipeline Insight, 2024 - Product Thumbnail Image

Arteriovenous Malformations - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Cardiac Amyloidosis - Pipeline Insight, 2024 - Product Thumbnail Image

Cardiac Amyloidosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Cardiac Insufficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Cardiac Insufficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Venous Ulceration - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Venous Ulceration - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024 - Product Thumbnail Image

Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more